INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Clinical Research Trends And IRB Expectations For 2026

  Oversight in 2026 requires adaptability as AI, consent standards, and regulatory uncertainty challenge sponsors and IRBs to balance ethics with innovation through proactive planning and collaboration.

• Beyond Go-Live: The True RTSM Quality Test

  Go‑live is only the beginning. This clip highlights how RTSM performance evolves over years of real‑world use — and why long‑term flexibility is just as important as a clean launch.

• Navigating Disclosure Complexity: The Power Of Human-Centered AI

  Identify key regulatory hurdles that sponsors face when integrating Artificial Intelligence (AI), as well as the impact of AI on clinical trial disclosure and transparency.

• Drilling Down On Diversity And Feasibility

  A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.

• Anthropic's Stainless Acquisition: What It Means For Clinical Trials

  6/5/2026

  As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  8/22/2025

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  4/1/2026

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• Open-Source Technologies Within Clinical Data Science

  11/21/2025

  Accelerate innovation in clinical trials by embracing open-source technologies that enhance data analysis, improve scalability, and unlock advanced predictive and machine-learning capabilities.

• Setting A New Client Standard In Study Closeout Timelines

  4/4/2025

  Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.